Tower Research Capital LLC (TRC) - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 1 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$59,902
+406.4%
34,827
+474.1%
0.00%
Q2 2023$11,829
+65616.7%
6,066
-9.3%
0.00%
-100.0%
Q1 2023$18
-14.3%
6,689
+11.7%
0.00%0.0%
Q4 2022$21
-99.9%
5,990
-51.4%
0.00%0.0%
Q3 2022$31,000
+138.5%
12,325
+134.0%
0.00%
Q2 2022$13,000
-86.7%
5,266
-77.9%
0.00%
-100.0%
Q1 2022$98,000
+71.9%
23,855
+438.7%
0.00%0.0%
Q4 2021$57,000
-66.1%
4,428
-71.5%
0.00%
-75.0%
Q3 2021$168,000
+158.5%
15,524
+116.9%
0.00%
+100.0%
Q2 2021$65,000
-30.1%
7,157
-26.9%
0.00%0.0%
Q1 2021$93,000
+244.4%
9,787
+43.9%
0.00%
+100.0%
Q4 2020$27,000
-69.0%
6,800
-79.3%
0.00%0.0%
Q3 2020$87,000
+93.3%
32,841
+385.6%
0.00%
-50.0%
Q2 2020$45,000
+542.9%
6,763
+739.1%
0.00%
Q3 2019$7,0000.0%806
+56.5%
0.00%
Q1 2019$7,000
+600.0%
515
+560.3%
0.00%
Q4 2018$1,000780.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders